
Loading, please wait...

Loading, please wait...

Accurate risk stratification remains essential for managing resectable non-small cell lung cancer. In recent decades, pulmonary adenocarcinoma grading has evolved considerably to help clinicians predict oncologic outcomes and tailor adjuvant therapies. Pulmonary adenocarcinoma exhibits extensive histological heterogeneity, which poses significant challenges for pathologists and thoracic oncologists attempting to establish reliable prognostic categories. Although several architectural classification models have gained widespread adoption, pathologists frequently seek refined systems that capture aggressive microscopic invasion patterns. Recent investigations emphasize that standard architectural assessment alone may fail to capture subtle mechanisms of tumor dissemination. Consequently, combining architectural differentiation with invasion parameters provides a more robust prognostic framework. A landmark clinical investigation conducted at the University of Szeged systematically evaluated several histological stratification schemes in resected lung cancer cohorts. By analyzing overall survival and recurrence-free survival, researchers demonstrated that integrating architectural parameters with spread through air spaces provides superior prognostic accuracy compared to traditional models. These insights underscore the necessity of standardizing routine pathological assessments across thoracic surgical oncology centers.
Histopathologic evaluation of lung adenocarcinoma historically relied on identifying predominant growth patterns, such as lepidic, acinar, papillary, micropapillary, and solid architectures. While the classic predominant-pattern classification offered meaningful prognostic separation, it frequently overlooked aggressive minor components. For instance, even small fractions of micropapillary or solid growth patterns can drive rapid postoperative recurrence. To resolve these limitations, international pathology consensus groups introduced multi-tiered grading systems that incorporate both the predominant and secondary high-grade components. Furthermore, recent classification updates recognize complex glandular and cribriform patterns as high-grade architectural phenotypes. However, despite these notable advancements, standard architectural grading systems do not always account for dynamic tumor-host interface behaviors. Independent invasive patterns, such as lymphovascular space invasion, visceral pleural invasion, and spread through air spaces, carry profound prognostic weight. Clinicians increasingly recognize that relying solely on cellular architecture without assessing cellular detachment mechanisms leaves critical prognostic gaps. Therefore, modern thoracic oncology demands comprehensive stratification models that bridge pure architectural morphology with micro-invasive phenotypes.
The retrospective cohort study conducted at the clinic of Szeged evaluated 304 patients who underwent surgical resection for lung adenocarcinoma between 2010 and 2016. Researchers comprehensively reviewed all histological slides to record morphological patterns, invasive descriptors, and clinical outcomes. Multivariate survival analyses revealed compelling prognostic determinants for overall survival and recurrence-free survival. Specifically, for overall survival, architectural grade combined with spread through air spaces emerged as an exceptionally powerful independent predictor, demonstrating a hazard ratio of 4.38. Additionally, the type of surgical resection, lymphovascular invasion, and vascular spread retained independent prognostic significance. In parallel, multivariate analysis of recurrence-free survival demonstrated that pathologic stage, vascular spread, and architectural grade combined with spread through air spaces served as significant independent prognosticators. Most notably, subgroup analyses excluding other adverse histological factors confirmed that this integrated grading scheme maintained its robust prognostic superiority. These statistical findings emphasize that combining architectural differentiation with spread through air spaces outclasses traditional single-parameter grading frameworks in postoperative risk prediction.
Spread through air spaces, commonly abbreviated as STAS, represents a distinct pattern of tumor progression characterized by micropapillary clusters, solid nests, or single malignant cells spreading through alveolar spaces beyond the main tumor edge. Pathologists and thoracic surgeons recognize STAS as a potent marker of aggressive tumor biology and local recurrence. When malignant cells detach and drift through distal airspaces, they can seed secondary intra-parenchymal foci that conventional macroscopic surgical margins might fail to clear. Consequently, patients harboring STAS-positive lesions frequently experience elevated locoregional and distant recurrence rates following sublobar resection. Incorporating STAS into conventional architectural grading systems addresses the biological gap between cellular differentiation and invasive dissemination. While high-grade patterns like solid or micropapillary architecture reflect intrinsic dedifferentiation, STAS captures active anatomical migration. Thus, evaluating these parameters together provides an accurate reflection of biological aggressiveness, allowing oncology teams to identify high-risk patients who require intensified post-resection monitoring or adjuvant systemic therapy.
The prognostic superiority of combining architectural grade with STAS carries major clinical implications for thoracic surgeons and clinical oncologists. In modern surgical oncology, limited resections such as segmentectomy and wedge resection have gained popularity for early-stage peripheral lung cancers. However, data increasingly indicate that tumors exhibiting high-grade architecture or STAS have significantly higher recurrence rates when treated with sublobar resections instead of standard lobectomies. Pathologists can help surgical teams optimize operative approaches by identifying these adverse histological parameters in rapid intraoperative or final pathological reports. Furthermore, accurate postoperative stratification informs multidisciplinary tumor boards regarding the administration of adjuvant chemotherapy, targeted therapies, or immune checkpoint inhibitors. Patients classified into high-risk categories based on combined grading might benefit from closer radiological surveillance protocols. Ultimately, implementing this refined risk-stratification method bridges routine pathology reporting with personalized surgical and medical oncologic decision-making.
Adopting an integrated grading approach requires pathologists to implement standardized slide review protocols and consistent diagnostic criteria. First, pathologists must evaluate total tumor architecture, accurately documenting the percentages of lepidic, acinar, papillary, micropapillary, and solid components. Second, pathologists must meticulously examine alveolar parenchyma surrounding the main tumor boundary to detect floating tumor cell clusters while carefully differentiating authentic STAS from mechanical artifacts, such as knife tracking or loose tissue debris. Although distinguishing true detachment from processing artifacts requires expert histological assessment, established pathological consensus criteria offer reliable diagnostic clarity. In addition, future clinical trials should validate this combined grading methodology across diverse multi-ethnic populations and prospectively evaluate its role in guiding adjuvant therapeutic choices. As digital pathology and artificial intelligence image analysis advance, automated pattern recognition tools may further assist pathologists in quantifying architectural fractions and detecting subtle air space dissemination with high reproducibility.
Spread through air spaces refers to the microscopic dissemination of tumor cell clusters, micropapillary structures, or single cells into alveolar air spaces beyond the edge of the main lung tumor. This invasive pattern represents an aggressive biological feature that correlates with higher postoperative recurrence rates, particularly in patients who undergo sublobar resections rather than anatomical lobectomies.
While architectural grading assesses the intrinsic differentiation patterns of the tumor, it does not directly capture cell detachment and intra-alveolar migration. By combining architectural differentiation with the presence of STAS, pathologists evaluate both cytological aggressiveness and anatomical invasiveness. This comprehensive approach yields significantly stronger hazard ratios for overall survival and recurrence-free survival than evaluating architecture alone.
Identifying high architectural grade or positive STAS signals a substantial risk for locoregional cancer recurrence. Thoracic surgeons often prefer anatomical lobectomy over sublobar or wedge resections when these features are identified. Furthermore, multidisciplinary oncology teams use these adverse findings to justify intensified postoperative imaging surveillance and evaluate the potential benefits of adjuvant systemic therapies for affected patients.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Qualified healthcare professionals should exercise their independent clinical judgment when interpreting clinical data. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A single-center study demonstrates that architectural grade combined with spread through air spaces (STAS) provides superior prognostic accuracy for overall and recurrence-free survival in resected pulmonary adenocarcinomas, outperforming traditional grading models.
4 weeks back

Systemic amyloidosis management is undergoing a therapeutic revolution. This clinical review synthesizes updates from the International Society of Amyloidosis, detailing novel plasma cell therapies, TTR stabilizers, silencers, translational models, and artificial intelligence in drug development.
Today

A retrospective study of 824 patients undergoing over 2,200 intradetrusor onabotulinumtoxinA injections identifies sex- and etiology-specific predictors of 2-week post-void residual, highlighting the influence of baseline residual volumes, toxin dosage, and distinct urodynamic parameters on urinary retention risk.
Today

The US FDA has granted approval to the SELUTION SLR drug-eluting balloon for treating coronary in-stent restenosis. This milestone introduces a sustained-release sirolimus platform that eliminates the need for additional permanent metallic stents while maintaining robust vascular healing and luminal patency.
Today

The Thumbs-Out Classification (TOC) is a reliable screening tool for detecting thumb-in-palm deformity in children with cerebral palsy. Utilizing traffic-light tiers for radial abduction, TOC enables clinicians to monitor upper limb function and initiate timely therapeutic or surgical interventions.
Today

A comprehensive review analyzes periconceptional GLP-1 receptor agonist exposure, revealing reassuring data on congenital anomalies and adverse perinatal outcomes while emphasizing the need for cautious patient counseling.
Today